Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Rockfields Properti Indonesia Tbk. (ROCK) vs Organon Pharma Indonesia Tbk. (SCPI)

Rockfields Properti Indonesia Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Rockfields Properti Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Rockfields Properti Indonesia Tbk. diperdagangkan di Rp2.070 (kapitalisasi pasar 3 T, volume 24 jam 29,1 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Rockfields Properti Indonesia Tbk. jauh lebih besar — sekitar 28,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

ROCKSCPI
Kapitalisasi Pasar
3 T104,4 M
Volume
29,1 rb
Lot
291
Perputaran
60,23 jt
Harga Rata-rata
2.069,86
Nilai Transaksi
60,23 jt
Harga Ekuilibrium Indikatif
2.070
Volume Ekuilibrium Indikatif
10

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ROCK
Lihat detail
SCPI
Lihat detail

Tentang Rockfields Properti Indonesia Tbk.

PT Rockfields Properti Indonesia, Tbk (formerly PT Nobel Properti Kencana) (“the Company” or “Holding Company”) was established in Republic of Indonesia based on the Notarial Deed No. 29 dated May 16, 2013 of Subiyanto Putro, S.H., M.Kn., Notary in Jakarta. The Company has commercially operated in April 2019.

Selengkapnya di halaman ROCK

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI